UnitedHealth Group’s (NYSE:UNH) “Outperform” Rating Reiterated at Sanford C. Bernstein

Sanford C. Bernstein reiterated their outperform rating on shares of UnitedHealth Group Incorporated (NYSE:UNH) in a research note released on Thursday, October 19th, The Fly reports. Sanford C. Bernstein currently has a $219.00 price objective on the healthcare conglomerate’s stock, up from their previous price objective of $210.00.

Several other research firms have also recently commented on UNH. Zacks Investment Research cut shares of UnitedHealth Group from a buy rating to a hold rating in a research report on Tuesday, October 10th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an overweight rating in a research report on Wednesday, June 28th. ValuEngine cut shares of UnitedHealth Group from a buy rating to a hold rating in a report on Thursday, October 5th. Deutsche Bank AG raised their target price on shares of UnitedHealth Group from $187.00 to $197.00 and gave the stock a buy rating in a report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. restated an outperform rating and set a $205.00 target price (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and a consensus price target of $215.27.

UnitedHealth Group (NYSE:UNH) traded up 1.65% during trading on Thursday, reaching $212.60. The company’s stock had a trading volume of 4,385,348 shares. UnitedHealth Group has a one year low of $136.22 and a one year high of $212.77. The stock has a 50-day moving average of $198.15 and a 200 day moving average of $186.99. The firm has a market capitalization of $210.26 billion, a P/E ratio of 24.14 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.17 earnings per share. On average, equities research analysts predict that UnitedHealth Group will post $9.99 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group’s (NYSE:UNH) “Outperform” Rating Reiterated at Sanford C. Bernstein” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2017/10/28/unitedhealth-group-incorporated-unh-earns-outperform-rating-from-sanford-c-bernstein.html.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the transaction, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the company’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders have sold 77,149 shares of company stock worth $15,182,242 over the last ninety days. Insiders own 0.89% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Patriot Financial Group Insurance Agency LLC raised its holdings in UnitedHealth Group by 1,722.9% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the last quarter. Blue Chip Partners Inc. bought a new position in UnitedHealth Group during the 2nd quarter worth approximately $110,000. Kings Point Capital Management raised its holdings in UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the last quarter. Bruderman Asset Management LLC bought a new position in UnitedHealth Group during the 2nd quarter worth approximately $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the last quarter. 86.09% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply